Andrew John Oakley insider trades
Open-market stock purchases and sales by Andrew John Oakley, Director at Onconetix, Inc, from SEC Form 4 filings since Mar 23, 2025.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- ONCO Onconetix, Inc: other filings, last Aug 15, 2025